DNA
Ginkgo Bioworks Holdings, Inc.Company with tickers: DNA, DNABW
CIK
1830214
CUSIP
37611X209
Shares Outstanding
53,361,141
13F Activity (30d)
146 filings
143 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $38,230,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | $4,090,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $70,923,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-80,972,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-90,957,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.68 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | — |